Your session is about to expire
← Back to Search
Selective Serotonin Reuptake Inhibitor (SSRI)
A for Obsessive-Compulsive Disorder
Phase 4
Waitlist Available
Led By John H Greist, MD
Research Sponsored by Rogers Center for Research & Training, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Men and women aged 18 years, with OCD of at least 1 year's duration, meeting DSM-IV diagnostic criteria, and having a baseline Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) score of 18.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This study will test the hypotheses that: 1. 12 weeks of Luvox-CR plus web-based Cognitive-Behavioral Therapy (CBT) \[CT-STEPS\] will produce greater symptom relief of OCD than treatment with Luvox-CR alone; and, 2. subjects receiving 12 weeks of CT-STEPS added to Luvox-CR treatment after 12-weeks of Luvox-CR monotherapy will experience greater OCD symptom relief (from weeks 12-24) than those continuing Luvox-CR treatment and having access to CT-STEPS from week one. 3. subjects who begin CT-STEPS at week 12 will be more likely to complete it than those who begin CT-STEPS at baseline.
Eligible Conditions
- Obsessive-Compulsive Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
1Treatment groups
Experimental Treatment
Group I: AExperimental Treatment2 Interventions
Effectiveness of Luvox CR plus Web-based CBT for OCD
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Therapy
2003
Completed Phase 4
~1210
Find a Location
Who is running the clinical trial?
Rogers Center for Research & Training, Inc.Lead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
John H Greist, MDPrincipal InvestigatorThe Rogers Center for Research & Training, Inc.
1 Previous Clinical Trials
20 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger